Important Information for Visitors

Privacy Policy    Disclaimer   Contact Us

Home

© Copyright 2016 Topdown Charts Limited

A Familiar if Ominous Sign in the US IPO Market

March 13, 2018

UPDATE (7 April 2019): The 2018 figure came in at a new record high of 81%, which both highlights an interesting apparent trend, and will no doubt spur some to think of the parallels between now and the heady heights of the dot-com bubble.  See below for updated chart.

 

 

Also worth noting is this chart of the breakdown, and the proportion of tech (and biotech) IPOs.  Biotech is a big part of this story, and to be fair it probably makes sense for Biotech companies to come to market with negative earnings as they arguably should be more focused on R&D than short-term P&L.  Still, it shows the more speculative nature of IPOs in the last couple of years.

 

 

 

ORIGINAL POST: As the title suggests, a familiar if ominous sign has emerged in the US IPO market.  As I've previously written on a number of times, studying trends and statistics in IPO statistics (initial public offering) can yield key insights on the state of the equity market as a whole and the resultant risk vs opportunity outlook.

 

The chart in today's blog comes from a discussion on the trends in the US IPO market from the Weekly Macro Themes report. That discussion aside from the negative earnings aspect, also looked at median age of IPO, proportion of foreign IPOs, and the pace of withdrawals and filings.

 

As alluded to, the chart shows the proportion of US IPOs with negative earnings.

 

At 76% the proportion of US IPOs with "earnings less than 0"... i.e. loss making companies, was the highest level since 1999 (second equal to the absolute highest in the year 2000). It's an intriguing statistic and one that instantly evokes parallels to the dot com mania.  Certainly, this is the sort of thing you typically see toward the end of a market cycle.

 

Diving into the detail - note the data is from the fine work conducted by Jay R Ritter of the University of Florida - the top culprit was Biotech companies, with 97% of biotech IPOs in the loss making camp.  Second place, no prizes for guessing, was Technology companies at 83%.  But interestingly enough that left 'all other companies' at 57% - which is actually a record high.

 

So it adds to a number of signs that we are "late cycle", whether it's the business cycle or the market cycle. But then again, late-cycle does not necessarily mean end-of-cycle, and as the year 2000 showed us so dramatically, these things can overshoot.  I would not say a speculative overshoot is my base case, but from a risk management standpoint (thinking about both sides of the coin), it's not something you rule out, particularly when you see animal spirits truly getting to work.

 

 

This article originally appeared as a submission at See It Market

 

 

Follow us on:

LinkedIn https://www.linkedin.com/company/topdown-charts

Twitter http://www.twitter.com/topdowncharts

 

 

Please reload

Follow us for updates:
  • Twitter Social Icon
  • LinkedIn Social Icon
Subscribe:

Top 5 Charts Of The Week

Institutional Reports

-Weekly Macro Themes

-Global Cross Asset Monitor

-Monthly Chartbook

access our exclusive research for deeper insights:

 

>>  Become a Client  <<

Search By Tags
Archive
Please reload

Important Notice

We offer exclusive insights for institutional clients with our suite of multi-asset investment research reports, personalized service, & global perspective.

Take a trial today...

Become a Client